FDA inspection
Global Blood Therapeutics, Inc.: FDA inspection ending Aug 12, 2019
FDA inspection 1099869 · Voluntary Action Indicated (VAI) · South San Francisco, CA
Key facts
| Inspection ID | 1099869 |
|---|---|
| Firm | Global Blood Therapeutics, Inc. |
| FEI number | 3014009624 |
| Address | 171 Oyster Point Blvd |
| City | South San Francisco |
| State | CA |
| ZIP | 94080 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Aug 12, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data